FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5592 | 26436-5592-1 | Sildenafil Citrate | 50 mg | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5591 | 26436-5591-1 | Sildenafil Citrate | 110 mg | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5086 | 26436-5086-1 | Tadalafil | 25 mg | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-0059 | 26436-0059-1 | Tadalafil | 20 mg | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5457 | 26436-5457-1 | Testosterone | 25 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5403 | 26436-5403-1 | Testosterone | 4 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5584 | 26436-5584-1 | Tetracaine; Lidocaine; Benzocaine | 100 mg/1 g; 100 mg/1 g; 200 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5585 | 26436-5585-1 | Tetracaine; Lidocaine; Benzocaine | 40 mg/1 g; 80 mg/1 g; 200 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5217 | 26436-5217-1 | Tretinoin; Hydroquinone | .6 mg/1 g; 40 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5549 | 26436-5549-1 | Tretinoin; Hydroquinone | .5 mg/1 g; 40 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5578 | 26436-5578-1 | Diclofenac | 160 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5553 | 26436-5553-1 | Estriol; Estradiol | 1 mg/1 g; 1 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5423 | 26436-5423-1 | Estriol; Testosterone; Estradiol | 3.2 mg/1 g; 5 mg/1 g; .8 mg/1 g | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5010 | 26436-5010-1 | Folic Acid | 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5049 | 26436-5049-1 | Alprostadil | 20 ug/1 mL | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5588 | 26436-5588-1 | Methylcobalamin | 1000 ug | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-5558 | 26436-5558-1 | Nadide | 50 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| Hybrid Pharma | 079665742 | 26436-0724 | 26436-0724-1 | Naltrexone | 2 mg | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-6509 | 71266-6509-1 | Phenol | 60 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-1015 | 71266-1015-2 | Betamethasone Sodium Phosphate | 6 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8526 | 71266-8526-1 | Phenylephrine Hydrochloride | 15 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 6 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-6350 | 71266-6350-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8210 | 71266-8210-5 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8210 | 71266-8210-1 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-1070 | 71266-1070-2 | Triamcinolone Acetonide | 40 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-1070 | 71266-1070-1 | Triamcinolone Acetonide | 40 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | Trisodium Citrate Dihydrate | 40 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | |||
| JCB Laboratories LLC | 177167470 | 71266-6660 | 71266-6660-1 | Trisodium Citrate Dihydrate; Gentamicin Sulfate | 40 mg/1 mL; .32 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8220 | 71266-8220-1 | Tropicamide; Ketorolac Tromethamine; Proparacaine Hydrochloride; Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 4 mg/1 mL; 1 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8585 | 71266-8585-1 | Vancomycin Hydrochloride | 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8110 | 71266-8110-1 | Epinephrine | 1 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .5 mg/1 mL; 40 mg/1 mL; 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-6477 | 71266-6477-5 | Iohexol | 240 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8231 | 71266-8231-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 100 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8230 | 71266-8230-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8230 | 71266-8230-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-6412 | 71266-6412-2 | Mitomycin | .5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| JCB Laboratories LLC | 177167470 | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 8 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-049 | 68985-049-91 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-004 | 68985-004-94 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 20 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-95 | Succinylcholine Chloride | 20 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 5 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 6 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 1 mg/1 mL | 2022-1 | valid | 2026-11-12 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-95 | Heparin Sodium | 10 U/1 mL | 2022-1 | valid | 2026-11-12 |